Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a pseudogene similar to a portion of the heterogeneous nuclear ribonucleoprotein H2 gene. Pseudogenes are genomic sequences that resemble known genes but have lost their ability to code for a functional protein, typically due to mutations or incomplete transcriptional/translation capacity[1][5]. Although previously considered "junk DNA," many pseudogenes are now known to participate in regulatory networks affecting gene expression. They can act through various mechanisms, such as serving as decoys for microRNAs or producing long non-coding RNAs that alter gene regulation epigenetically[1][3][5]. However, not all pseudogenes are functional, and there is usually no protein product, making them irrelevant as direct therapeutic targets for drug development.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Similar to part of the heterogeneous nuclear ribonucleoprotein H2 pseudogene (ENSG00000230621).